Modified Finnegan Neonatal Abstinence Score (NAS)

ورودی‌های بالینی بیمار

پنل نتیجه و تصمیم بالینی
در انتظار ورودی‌ها
nas score
—points
آماده برای ارزیابی

پارامترهای بالینی بیمار را در فرم روبرو وارد کنید و روی «محاسبه» کلیک نمایید تا نمره، طبقه خطر و اقدامات فوری نمایش داده شوند.

طبقات خطر و بازه‌های امتیاز:
  • No Treatment0–7
  • Monitor Closely8–11
  • Treat12–50
Direct Clinical Answer

The Modified Finnegan Neonatal Abstinence Score (NAS) calculates calculating weight-based pediatric dosing and evaluating age-specific physiological parameters. Key inputs include cry. Scores guide titrating weight-adjusted medication dosing, monitoring developmental safety, and evaluating treatment response. This standardized assessment improves clinical decision safety and bedside patient management.

Clinical Guidelines & Evidence

Stratifies severity of opioid withdrawal in neonates and guides pharmacologic treatment decisions

Clinical Indication

The Modified Finnegan Neonatal Abstinence Score (NAS) is indicated for bedside clinical practice to support Stratifies severity of opioid withdrawal in neonates and guides pharmacologic treatment decisions. It assists healthcare providers in standardizing clinical assessment and therapeutic decision-making.

Target Population

Target population comprises Neonates, infants, children, and adolescents from birth up to 18 years of age. Clinical application is indicated across Pediatric emergency departments, pediatric inpatient wards, PICU, and pediatric primary care.

Limitations & Contraindications

Adult scoring thresholds and pharmacological formulas must never be applied to pediatric patients.

Clinical Pearls & Action Plan

Accurate weight-based dosing and age-stratified physiological vital sign reference ranges are foundational in pediatric clinical practice. Guideline pearl: Two consecutive scores ≥12 OR three consecutive scores ≥8 indicate need for pharmacologic treatment.

Formula & Variables:

Sum of points from all assessed categories: CNS disturbances (cry, sleep, reflexes, tremors, tone, excoriation, jerks, convulsions), metabolic/vasomotor (sweating, fever, yawning, mottling), respiratory (flaring, rate, sneezing, stuffiness), and GI (feeding, vomiting, stools).

Input Parameters

NameTypeRequiredDescription
crystringYesCrying pattern assessment
sleepstringYesSleep duration after feeding
moro_reflexstringYesMoro reflex activity assessment
tremorsstringYesTremor severity and occurrence
increased_muscle_tonestringYesPresence of increased muscle tone
excoriationstringYesPresence of skin excoriation from excessive movement
myoclonic_jerksstringYesPresence of myoclonic jerks
generalized_convulsionsstringYesPresence of generalized convulsions
sweatingstringYesPresence of excessive sweating
hyperthermiastringYesBody temperature elevation
frequent_yawningstringYesFrequent yawning (>3-4 times per interval)
mottlingstringYesPresence of skin mottling
nasal_flaringstringYesPresence of nasal flaring
respiratory_ratestringYesRespiratory rate and retractions
sneezingstringYesFrequent sneezing (>3-4 times per interval)
nasal_stuffinessstringYesPresence of nasal stuffiness
excessive_suckingstringYesExcessive or frantic sucking behavior
poor_feedingstringYesPoor feeding with infrequent or uncoordinated suck
regurgitationstringYesRegurgitation (≥2 times during/post feeding)
projectile_vomitingstringYesPresence of projectile vomiting
loose_stoolsstringYesLoose stools (curds/seedy)
watery_stoolsstringYesWatery stools

Score Interpretation & Guidance

RangeStageDescription
0–7No TreatmentMild or no withdrawal symptoms
8–11Monitor CloselyModerate withdrawal symptoms
12–50TreatSevere withdrawal symptoms

Evidence-Based References (EBM)

  • Finnegan LP, Connaughton JF Jr, Kron RE, Emich JP. Neonatal abstinence syndrome: assessment and management. Addict Dis. 1975;2(1-2):141-58.
  • Jansson LM, Velez M, Harrow C. The opioid-exposed newborn: assessment and pharmacologic management. J Opioid Manag. 2009 Jan-Feb;5(1):47-55.
  • Hudak ML, Tan RC; Committee on Drugs; Committee on Fetus and Newborn; American Academy of Pediatrics. Neonatal drug withdrawal. Pediatrics. 2012 Feb;129(2):e540-60. doi: 10.1542/peds.2011-3212.DOI: 10.1542/peds.2011-3212

Related calculators